Ausgabe 1/2018
Inhalt (13 Artikel)
Does Parkinson’s disease start in the gut?
Arthur Lionnet, Laurène Leclair-Visonneau, Michel Neunlist, Shigeo Murayama, Masaki Takao, Charles H. Adler, Pascal Derkinderen, Thomas G. Beach
Multiple system atrophy: experimental models and reality
Cassia Overk, Edward Rockenstein, Elvira Valera, Nadia Stefanova, Gregor Wenning, Eliezer Masliah
MSA prions exhibit remarkable stability and resistance to inactivation
Amanda L. Woerman, Sabeen A. Kazmi, Smita Patel, Yevgeniy Freyman, Abby Oehler, Atsushi Aoyagi, Daniel A. Mordes, Glenda M. Halliday, Lefkos T. Middleton, Steve M. Gentleman, Steven H. Olson, Stanley B. Prusiner
Spread of aggregates after olfactory bulb injection of α-synuclein fibrils is associated with early neuronal loss and is reduced long term
Nolwen L. Rey, Sonia George, Jennifer A. Steiner, Zachary Madaj, Kelvin C. Luk, John Q. Trojanowski, Virginia M.-Y. Lee, Patrik Brundin
Polygenic hazard score: an enrichment marker for Alzheimer’s associated amyloid and tau deposition
Chin Hong Tan, Chun Chieh Fan, Elizabeth C. Mormino, Leo P. Sugrue, Iris J. Broce, Christopher P. Hess, William P. Dillon, Luke W. Bonham, Jennifer S. Yokoyama, Celeste M. Karch, James B. Brewer, Gil D. Rabinovici, Bruce L. Miller, Gerard D. Schellenberg, Karolina Kauppi, Howard A. Feldman, Dominic Holland, Linda K. McEvoy, Bradley T. Hyman, David A. Bennett, Ole A. Andreassen, Anders M. Dale, Rahul S. Desikan
Uncoupling N-acetylaspartate from brain pathology: implications for Canavan disease gene therapy
Georg von Jonquieres, Ziggy H. T. Spencer, Benjamin D. Rowlands, Claudia B. Klugmann, Andre Bongers, Anne E. Harasta, Kristina E. Parley, Jennie Cederholm, Orla Teahan, Russell Pickford, Fabien Delerue, Lars M. Ittner, Dominik Fröhlich, Catriona A. McLean, Anthony S. Don, Miriam Schneider, Gary D. Housley, Caroline D. Rae, Matthias Klugmann
Comprehensive molecular characterisation of epilepsy-associated glioneuronal tumours
Thomas J. Stone, Angus Keeley, Alex Virasami, William Harkness, Martin Tisdall, Elisa Izquierdo Delgado, Alice Gutteridge, Tony Brooks, Mark Kristiansen, Jane Chalker, Lisa Wilkhu, William Mifsud, John Apps, Maria Thom, Mike Hubank, Tim Forshew, J. Helen Cross, Darren Hargrave, Jonathan Ham, Thomas S. Jacques
A knock-in/knock-out mouse model of HSPB8-associated distal hereditary motor neuropathy and myopathy reveals toxic gain-of-function of mutant Hspb8
Delphine Bouhy, Manisha Juneja, Istvan Katona, Anne Holmgren, Bob Asselbergh, Vicky De Winter, Tino Hochepied, Steven Goossens, Jody J. Haigh, Claude Libert, Chantal Ceuterick-de Groote, Joy Irobi, Joachim Weis, Vincent Timmerman
CASQ1 mutations impair calsequestrin polymerization and cause tubular aggregate myopathy
Johann Böhm, Xavière Lornage, Frederic Chevessier, Catherine Birck, Simona Zanotti, Paola Cudia, Monica Bulla, Florence Granger, Mai Thao Bui, Maxime Sartori, Christiane Schneider-Gold, Edoardo Malfatti, Norma B. Romero, Marina Mora, Jocelyn Laporte
Regional levels of physiological α-synuclein are directly associated with Lewy body pathology
Daniel Erskine, Lina Patterson, Athanasios Alexandris, Peter S. Hanson, Ian G. McKeith, Johannes Attems, Christopher M. Morris
Accumulation of dysfunctional SOD1 protein in Parkinson’s disease is not associated with mutations in the SOD1 gene
Benjamin G. Trist, Jennifer A. Fifita, Sarah E. Freckleton, Dominic J. Hare, Simon J. G. Lewis, Glenda M. Halliday, Ian P. Blair, Kay L. Double
Phenotyping cognitive impairment in dialysis patients: insights from experimental mouse models
Dearbhla M. Kelly